These data align with the GSEA data for DEGs between leukemogenic Cbfb-MYH11 variants and controls, which also identified pathways related to the immune response and CBFA2T3 targets (Figure 4E), highlighting the importance of these pathways in the development of Cbfb-MYH11–induced leukemia. This evidence concerns the gene MYH11 and leukemia.